Conclusion:The treatment of senile breast cancer still favors the operative treatment,postoperative radiotherapy,chemotherapy and endocrinotherapy should be app...
Background : Bendamustine, a bifunctional alkylating agent with anticipated purin-like properties is active in metastatic breast cancer (MBC) patients.
The possibility of postirradiation sarcoma after radiation therapy should not be a major factor influencing treatment decision in the patient with breast cancer.
In order to study the role of bone sialoprotein(BSP) in the metastasis of breast cancer cells to bones,a breast cancer cell line stably expressing BSP should be established.
But an estimated 8 to 15 percent of DCIS patients who have the lesion removed by lumpectomy will develop breast cancer in the 10 years following their surgery.
When Genae Girard received a diagnosis of breast cancer in 2006, she knew she would be facing medical challenges and high expenses.But she did not expect to run into patent problems.